Tranexamic Acid Use During Lactation
Lactating mothers can safely take tranexamic acid while breastfeeding, as the drug shows minimal transfer to breast milk and no adverse effects on infants have been documented.
Safety Profile in Breastfeeding
The evidence strongly supports continuation of breastfeeding while taking tranexamic acid. A prospective controlled study specifically evaluated 21 breastfeeding mothers taking tranexamic acid and found no increase in adverse outcomes compared to controls 1. Importantly:
- No adverse infant effects: Only 1 of 21 infants exposed to tranexamic acid through breast milk showed possible drug effects (restlessness), which was comparable to the control group (1 of 42 infants) 1
- Normal growth and development: All infants exposed through breastfeeding demonstrated normal developmental milestones, with growth patterns similar to unexposed infants 1
- Minimal milk transfer: Previous pharmacokinetic estimates indicate very low drug exposure through breast milk 1
Clinical Context for Postpartum Use
If tranexamic acid is being used for postpartum hemorrhage (the most common indication in lactating mothers), the WHO strongly recommends its use when clinically indicated 2. The maternal mortality benefit from treating postpartum hemorrhage far outweighs any theoretical risk to the breastfeeding infant.
Dosing for Postpartum Hemorrhage
When treating postpartum hemorrhage in a breastfeeding mother:
- Initial dose: 1 g (100 mg/mL) intravenously over 10 minutes 2
- Second dose: Additional 1 g IV if bleeding continues after 30 minutes or restarts within 24 hours 2
- Critical timing: Must be administered within 3 hours of birth for efficacy; administration beyond 3 hours may be harmful 2
Important Caveats
Route of administration matters critically: Tranexamic acid injection is for intravenous use only. Serious adverse reactions including seizures and cardiac arrhythmias have occurred with inadvertent intrathecal administration 3. This is a medication error that has caused maternal deaths 4.
Contraindications apply regardless of breastfeeding status:
Thromboembolic considerations: While tranexamic acid does not increase thrombotic risk in standard postpartum use, avoid concomitant use with pro-thrombotic medications including hormonal contraceptives 3. This is particularly relevant for postpartum mothers considering contraception options.
Practical Recommendation
Continue breastfeeding without interruption when taking tranexamic acid. The documented safety profile, minimal infant exposure, and absence of adverse outcomes support this approach 1. The maternal benefits of treating conditions like postpartum hemorrhage substantially outweigh any theoretical risk to the nursing infant.